共 50 条
Cyclo-Oxygenase-2 InhibitorsWhen Should They Be Used in the Elderly?
被引:0
|作者:
Ruth Savage
机构:
[1] University of Otago,New Zealand Pharmacovigilence Centre, Department of Preventive and Social Medicine
来源:
Drugs & Aging
|
2005年
/
22卷
关键词:
Ibuprofen;
Celecoxib;
Naproxen;
Rofecoxib;
Etoricoxib;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Chronic pain in the elderly is frequently a result of arthritic disorders, particularly osteoarthritis. The cyclo-oxygenase (COX)-2 inhibitors are as effective as standard NSAIDs for the relief of pain and for improving function in elderly patients with osteoarthritis and rheumatoid arthritis. COX-2 inhibitors increase the risk of serious gastroduodenal adverse reactions but there is evidence that they carry a lower risk for these adverse effects than standard NSAIDs, except when there is concurrent aspirin use. Since gastroduodenal disorders are the most frequently reported serious adverse effects of NSAIDs and these disorders occur more frequently in the elderly, COX-2 inhibitors offer an alternative to standard NSAIDs in this age group. However, they are not appropriate for many patients with cardiovascular and renal disease.
引用
收藏
页码:185 / 200
页数:15
相关论文